EPIPHYSEAL DYSPLASIA, MULTIPLE, 5
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Disease or Syndrome
|
2
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Granulomatous ileocolitis
|
disease |
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Degenerative myelopathy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hypotriglyceridemia
|
disease |
|
Disease or Syndrome
|
9
|
2
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Exacerbation of allergic asthma
|
disease |
|
Disease or Syndrome
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Metaphyseal chondrodysplasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Congenital Abnormality
|
20
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Multi-centric Castleman's Disease
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Methamphetamine dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
33
|
9
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Hearing Loss, High-Frequency
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
35
|
8
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Multiple Epiphyseal Dysplasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Congenital Abnormality
|
40
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Subclinical hypothyroidism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
40
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Major depression, single episode
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
42
|
14
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Generalized vitiligo
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
43
|
16
|
0.030 |
None |
1.000 |
3 |
|
2011 |
2012 |
Selective immunoglobulin A deficiency
|
disease |
|
Disease or Syndrome
|
45
|
23
|
0.010 |
None |
< 0.001 |
1 |
|
2009 |
2009 |
Plasma Cell Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
46
|
2
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
ADENOMAS AND ADENOCARCINOMAS
|
group |
Neoplasms
|
Neoplastic Process
|
51
|
2
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Ovarian cancer stage IV
|
disease |
|
Neoplastic Process
|
51
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adenocarcinoma in Situ
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
55
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Bronchitis
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
58
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Insulin Sensitivity
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Spindle cell hemangioma
|
disease |
Neoplasms
|
Neoplastic Process
|
68
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Immunoglobulin A deficiency (disorder)
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
72
|
25
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
mixed gliomas
|
disease |
Neoplasms
|
Neoplastic Process
|
76
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Bipolar I disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
83
|
46
|
0.310 |
None |
1.000 |
1 |
|
2007 |
2007 |
Rotavirus Infections
|
group |
Infections
|
Disease or Syndrome
|
84
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |